全文获取类型
收费全文 | 36150篇 |
免费 | 1538篇 |
国内免费 | 84篇 |
专业分类
耳鼻咽喉 | 138篇 |
儿科学 | 868篇 |
妇产科学 | 1135篇 |
基础医学 | 2993篇 |
口腔科学 | 531篇 |
临床医学 | 4104篇 |
内科学 | 8019篇 |
皮肤病学 | 313篇 |
神经病学 | 3551篇 |
特种医学 | 1109篇 |
外科学 | 3861篇 |
综合类 | 443篇 |
现状与发展 | 2篇 |
一般理论 | 3篇 |
预防医学 | 5842篇 |
眼科学 | 489篇 |
药学 | 1615篇 |
2篇 | |
中国医学 | 112篇 |
肿瘤学 | 2642篇 |
出版年
2024年 | 39篇 |
2023年 | 2655篇 |
2022年 | 4071篇 |
2021年 | 3514篇 |
2020年 | 3919篇 |
2019年 | 2117篇 |
2018年 | 1565篇 |
2017年 | 2063篇 |
2016年 | 1901篇 |
2015年 | 1579篇 |
2014年 | 3246篇 |
2013年 | 1846篇 |
2012年 | 1124篇 |
2011年 | 725篇 |
2010年 | 1621篇 |
2009年 | 1514篇 |
2008年 | 490篇 |
2007年 | 570篇 |
2006年 | 400篇 |
2005年 | 261篇 |
2004年 | 144篇 |
2003年 | 210篇 |
2002年 | 221篇 |
2001年 | 233篇 |
2000年 | 162篇 |
1999年 | 251篇 |
1998年 | 236篇 |
1997年 | 179篇 |
1996年 | 215篇 |
1995年 | 185篇 |
1994年 | 133篇 |
1993年 | 104篇 |
1992年 | 41篇 |
1991年 | 50篇 |
1990年 | 50篇 |
1989年 | 48篇 |
1988年 | 43篇 |
1987年 | 3篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1983年 | 6篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1974年 | 2篇 |
1972年 | 3篇 |
1965年 | 2篇 |
1963年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
《Autoimmunity reviews》2022,21(9):103143
Autoimmune diseases (AID) are increasingly prevalent conditions which comprise more than 100 distinct clinical entities that are responsible for a great disease burden worldwide. The early recognition of these diseases is key for preventing their complications and for tailoring proper management. In most cases, autoantibodies, regardless of their potential pathogenetic role, can be detected in the serum of patients with AID, helping clinicians in making a definitive diagnosis and allowing screening strategies for early -and sometimes pre-clinical- diagnosis. Despite their undoubted crucial role, in a minority of cases, patients with AID may not show any autoantibody, a condition that is referred to as seronegative AID. Suboptimal accuracy of the available laboratory tests, antibody absorption, immunosuppressive therapy, immunodeficiencies, antigen exhaustion, and immunosenescence are the main possible determinants of seronegative AID. Indeed, in seronegative AID, the diagnosis is more challenging and must rely on clinical features and on other available tests, often including histopathological evaluation and radiological diagnostic tests. In this review, we critically dissect, in a narrative fashion, the possible causes of seronegativity, as well as the diagnostic and management implications, in several AID including autoimmune gastritis, celiac disease, autoimmune liver disease, rheumatoid arthritis, autoimmune encephalitis, myasthenia gravis, Sjögren’s syndrome, antiphospholipid syndrome, and autoimmune thyroid diseases. 相似文献
12.
13.
《Journal of diabetes and its complications》2022,36(8):108255
AimsThe effect of Glucagon-like peptide 1 receptor agonists (GLP1 RA) on diabetic retinopathy (DR) remains controversial. Previous reviews combined data from randomized clinical trials (RCTs) with or without cardiovascular (CV) benefits and did not address confounders, therefore may have generated misleading results. The study aimed to examine the effect of GLP1RA on DR in type 2 diabetes (T2DM) in RCTs with or without CV benefits and distinguish the effect by major confounders.MethodsWe conducted electronic searches of multiple databases and a manual search using references lists. We included 13 RCTs examining the effect of GLP1 RA on health outcomes/adverse events including DR or DR complications in T2DM. We performed a random-effects model meta-analysis.ResultsGLP1RA was associated with an elevated risk of rapidly worsening DR in four major RCTs with CV benefits in T2DM (OR 1.23, 95 % CI 1.05–1.44). The association between GLP1 RA and DR was significant in subgroups of RCTs with length over 52 weeks (1.2, 1.00–1.43), using placebo as a comparator (1.22, 1.05–1.42). In subgroups with patients who had T2DM ≥10 years (1.19, 0.99–1.42) or with subjects enrolled from multiple countries (1.2, 0.99–1.46), the association appeared to be evident but did not reach statistical significance.ConclusionsGLP1 RA including liraglutide, semaglutide, and dulaglutide are associated with an increased risk of rapidly worsening DR in RCTs with CV benefits. Further data from clinical studies with longer follow-up purposefully designed for DR risk assessment, particularly including patients of established DR are warranted. 相似文献
14.
15.
16.
《Survey of ophthalmology》2023,68(4):815-820
An 8-year-old boy presented with acute visual loss in the right eye and nausea, vomiting, and diplopia. Imaging revealed a right orbital apex mass. Biopsy showed Langerhans cell histiocytosis (LCH), and the patient was diagnosed with isolated orbital LCH causing an orbital apex syndrome. A 12-month cytarabine chemotherapy course was begun, during which the patient developed bilateral optic disc edema. He was diagnosed with cytarabine-induced intracranial hypertension, which was successfully treated with acetazolamide. The cytarabine course was completed with complete resolution of the LCH lesion. The ophthalmologic relevance of this rare disorder is discussed. 相似文献
17.
18.
19.
20.